Cargando…
Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies
Tauopathies are neurodegenerative diseases characterized by tau inclusions in brain cells. Seed-competent tau species have been suggested to spread from cell to cell in a stereotypical manner, indicating that this may involve a prion-like mechanism. Although the intercellular mechanisms of transfer...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821971/ https://www.ncbi.nlm.nih.gov/pubmed/34563677 http://dx.doi.org/10.1016/j.ymthe.2021.09.020 |
_version_ | 1784646508797231104 |
---|---|
author | Leroux, Elodie Perbet, Romain Caillierez, Raphaëlle Richetin, Kevin Lieger, Sarah Espourteille, Jeanne Bouillet, Thomas Bégard, Séverine Danis, Clément Loyens, Anne Toni, Nicolas Déglon, Nicole Deramecourt, Vincent Schraen-Maschke, Susanna Buée, Luc Colin, Morvane |
author_facet | Leroux, Elodie Perbet, Romain Caillierez, Raphaëlle Richetin, Kevin Lieger, Sarah Espourteille, Jeanne Bouillet, Thomas Bégard, Séverine Danis, Clément Loyens, Anne Toni, Nicolas Déglon, Nicole Deramecourt, Vincent Schraen-Maschke, Susanna Buée, Luc Colin, Morvane |
author_sort | Leroux, Elodie |
collection | PubMed |
description | Tauopathies are neurodegenerative diseases characterized by tau inclusions in brain cells. Seed-competent tau species have been suggested to spread from cell to cell in a stereotypical manner, indicating that this may involve a prion-like mechanism. Although the intercellular mechanisms of transfer are unclear, extracellular vesicles (EVs) could be potential shuttles. We assessed this in humans by preparing vesicles from fluids (brain-derived enriched EVs [BD-EVs]). These latter were isolated from different brain regions in various tauopathies, and their seeding potential was assessed in vitro and in vivo. We observed considerable heterogeneity among tauopathies and brain regions. The most striking evidence was coming mainly from Alzheimer’s disease where the BD-EVs clearly contain pathological species that can induce tau lesions in vivo. The results support the hypothesis that BD-EVs participate in the prion-like propagation of tau pathology among tauopathies, and there may be implications for diagnostic and therapeutic strategies. |
format | Online Article Text |
id | pubmed-8821971 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | American Society of Gene & Cell Therapy |
record_format | MEDLINE/PubMed |
spelling | pubmed-88219712023-02-02 Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies Leroux, Elodie Perbet, Romain Caillierez, Raphaëlle Richetin, Kevin Lieger, Sarah Espourteille, Jeanne Bouillet, Thomas Bégard, Séverine Danis, Clément Loyens, Anne Toni, Nicolas Déglon, Nicole Deramecourt, Vincent Schraen-Maschke, Susanna Buée, Luc Colin, Morvane Mol Ther Original Article Tauopathies are neurodegenerative diseases characterized by tau inclusions in brain cells. Seed-competent tau species have been suggested to spread from cell to cell in a stereotypical manner, indicating that this may involve a prion-like mechanism. Although the intercellular mechanisms of transfer are unclear, extracellular vesicles (EVs) could be potential shuttles. We assessed this in humans by preparing vesicles from fluids (brain-derived enriched EVs [BD-EVs]). These latter were isolated from different brain regions in various tauopathies, and their seeding potential was assessed in vitro and in vivo. We observed considerable heterogeneity among tauopathies and brain regions. The most striking evidence was coming mainly from Alzheimer’s disease where the BD-EVs clearly contain pathological species that can induce tau lesions in vivo. The results support the hypothesis that BD-EVs participate in the prion-like propagation of tau pathology among tauopathies, and there may be implications for diagnostic and therapeutic strategies. American Society of Gene & Cell Therapy 2022-02-02 2021-09-24 /pmc/articles/PMC8821971/ /pubmed/34563677 http://dx.doi.org/10.1016/j.ymthe.2021.09.020 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Leroux, Elodie Perbet, Romain Caillierez, Raphaëlle Richetin, Kevin Lieger, Sarah Espourteille, Jeanne Bouillet, Thomas Bégard, Séverine Danis, Clément Loyens, Anne Toni, Nicolas Déglon, Nicole Deramecourt, Vincent Schraen-Maschke, Susanna Buée, Luc Colin, Morvane Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title | Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title_full | Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title_fullStr | Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title_full_unstemmed | Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title_short | Extracellular vesicles: Major actors of heterogeneity in tau spreading among human tauopathies |
title_sort | extracellular vesicles: major actors of heterogeneity in tau spreading among human tauopathies |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8821971/ https://www.ncbi.nlm.nih.gov/pubmed/34563677 http://dx.doi.org/10.1016/j.ymthe.2021.09.020 |
work_keys_str_mv | AT lerouxelodie extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT perbetromain extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT caillierezraphaelle extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT richetinkevin extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT liegersarah extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT espourteillejeanne extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT bouilletthomas extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT begardseverine extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT danisclement extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT loyensanne extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT toninicolas extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT deglonnicole extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT deramecourtvincent extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT schraenmaschkesusanna extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT bueeluc extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies AT colinmorvane extracellularvesiclesmajoractorsofheterogeneityintauspreadingamonghumantauopathies |